298 related articles for article (PubMed ID: 2774641)
21. Presence of anti-La(SS-B) is associated with binding to the 13-kD carboxyl terminus of 60-kD Ro(SS-A) in systemic lupus erythematosus.
Dickey WD; van Egmond JE; Hardgrave KL; Harley JB; Scofield RH
J Invest Dermatol; 1993 Apr; 100(4):412-6. PubMed ID: 8454905
[TBL] [Abstract][Full Text] [Related]
22. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
[TBL] [Abstract][Full Text] [Related]
23. Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?
Venables PJ; Shattles W; Pease CT; Ellis JE; Charles PJ; Maini RN
Clin Exp Rheumatol; 1989; 7(2):181-4. PubMed ID: 2736832
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus.
Derksen RH; Meilof JF
Arthritis Rheum; 1992 Aug; 35(8):953-9. PubMed ID: 1642661
[TBL] [Abstract][Full Text] [Related]
25. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
[TBL] [Abstract][Full Text] [Related]
26. Identification of the SS-A/Ro intracellular antigen with autoimmune sera.
Lieu TS; Jiang M; Steigerwald JC; Tan EM
J Immunol Methods; 1984 Jul; 71(2):217-28. PubMed ID: 6736660
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies reactive with small ribonucleoprotein antigens: a convergence of molecular biology and clinical immunology.
McNeilage LJ; Whittingham S; Mackay IR
J Clin Lab Immunol; 1984 Sep; 15(1):1-17. PubMed ID: 6210367
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
Zappi E; Sontheimer R
Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
[TBL] [Abstract][Full Text] [Related]
29. Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins.
Slobbe RL; Pruijn GJ; Damen WG; van der Kemp JW; van Venrooij WJ
Clin Exp Immunol; 1991 Oct; 86(1):99-105. PubMed ID: 1914239
[TBL] [Abstract][Full Text] [Related]
30. Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens.
Deng JS; Sontheimer RD; Gilliam JN
J Invest Dermatol; 1985 Feb; 84(2):86-90. PubMed ID: 3881537
[TBL] [Abstract][Full Text] [Related]
31. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
[TBL] [Abstract][Full Text] [Related]
32. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La.
Julkunen H; Kurki P; Kaaja R; Heikkilä R; Immonen I; Chan EK; Wallgren E; Friman C
Arthritis Rheum; 1993 Nov; 36(11):1588-98. PubMed ID: 8240435
[TBL] [Abstract][Full Text] [Related]
33. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex.
Tseng CE; Chan EK; Miranda E; Gross M; Di Donato F; Buyon JP
Arthritis Rheum; 1997 May; 40(5):936-44. PubMed ID: 9153557
[TBL] [Abstract][Full Text] [Related]
34. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
35. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
[TBL] [Abstract][Full Text] [Related]
36. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
[TBL] [Abstract][Full Text] [Related]
37. IgM and IgG subclass distribution of human anti-Ro/SSA 60 kDa autoantibodies.
Wahren M; Ringertz NR; Pettersson I
Scand J Immunol; 1994 Feb; 39(2):179-83. PubMed ID: 8296160
[TBL] [Abstract][Full Text] [Related]
38. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus.
Elkon KB; Culhane L
J Immunol; 1984 May; 132(5):2350-6. PubMed ID: 6715882
[TBL] [Abstract][Full Text] [Related]
39. Disparate locations of the 52- and 60-kDa Ro/SS-A antigens in cultured human keratinocytes.
Yell JA; Wang L; Yin H; McCauliffe DP
J Invest Dermatol; 1996 Oct; 107(4):622-6. PubMed ID: 8823371
[TBL] [Abstract][Full Text] [Related]
40. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
